Galactose and Fructose Disorders

Galactose and fructose disorders are a paired set of inborn errors of metabolism that USMLE Step 1 loves to test as a compare-and-contrast. Each category has a severe version and a benign version, and the exam exploits the fact that students lump them together. The core framework: galactosemia has two forms (classic galactosemia from GALT deficiency vs. galactokinase deficiency), and fructose disorders also split into two (hereditary fructose intolerance from aldolase B vs. essential fructosuria from fructokinase). Know which enzyme is deficient, what accumulates, and what the clinical consequences are — that's the backbone of every question.

The way USMLE Step 1 tests this is usually through a clinical vignette: a neonate with jaundice, cataracts, and E. coli sepsis after breastfeeding, or a child with hypoglycemia after eating fruit. You'll need to identify the disorder from the presentation and then reason about mechanism — not just memorize names. The passage might give you lab data (positive reducing substance, negative dipstick glucose) and ask what that means, or describe a dietary restriction and ask which metabolite would accumulate.

The biggest traps: students think galactokinase deficiency is the 'classic' galactosemia and miss that it only causes cataracts with no systemic toxicity. On the fructose side, students mix up essential fructosuria (benign, incidental finding) with hereditary fructose intolerance (serious, causes hypoglycemia and liver failure). And many students don't know that both galactose and fructose are reducing sugars — they'll show up on a urine reducing substance test but not on a standard dipstick, which tests glucose only. That lab distinction is a real Step 1 favorite.